Clinical Research Directory

Thulium Laser and Growth Factors for Androgenetic Alopecia

Sponsor: Universitätsklinikum Hamburg-Eppendorf

Summary

Androgenetic alopecia (AGA) is a common cause of hair loss worldwide. It mainly affects the frontal and parietal regions of the scalp in up to 70 % of men and 40 % of women and has a significant negative psychological and emotional impact on those affected. Various therapies are currently approved for the treatment of AGA in men and women, including topical minoxidil, topical or systemic finasteride, platelet-rich plasma and hair transplantation. In addition to these pharmacological and surgical interventions, laser therapies including thulium laser with growth factors have gained popularity. Despite the clinical use of the thulium laser with growth factors in combination with LED phototherapy, there are only a few studies to date that have adequately investigated the objective and patient-side benefits of this therapy.

Official title: Thulium Laser and Growth Factors for Androgenetic Alopecia - a Prospective, Clinical Study

Key Details

Conditions

Interventions

Locations (1)